Peter Zannikos

Phase I Trial and Pharmacokinetic Study of the Farnesyltransferase Inhibitor Tipifarnib in Children With Refractory Solid Tumors or Neurofibromatosis Type I and Plexiform Neurofibromas

Brigitte C. Widemann, Wanda L. Salzer, R.J. Arceci et al. · Journal of Clinical Oncology · 2006 · 145 citations · Full text

Pharmacokinetic and pharmacodynamic study of two doses of bortezomib in patients with relapsed multiple myeloma

Donna Reece, Dan M. Sullivan, Sagar Lonial et al. · Cancer Chemotherapy and Pharmacology · 2010 · 106 citations · Full text

Hematological Malignancy, Pharmacodynamic Study, Oncology +6

The effect of fluconazole on the clinical pharmacokinetics of methadone*

Malik N. Cobb, Jay Desai, Lawrence S. Brown et al. · Clinical Pharmacology & Therapeutics · 1998 · 98 citations

Drug Safety, Substance Abuse, Pharmacological Study +13

Validation and application of an LC–MS/MS method for quantitation of three fatty acid ethanolamides as biomarkers for fatty acid hydrolase inhibition in human plasma

Wenying Jian, Richard W. Edom, Naidong Weng et al. · Journal of Chromatography B · 2010 · 71 citations

Lipid Analysis, Biochemistry, Medicine +9

Effect of intranasal esketamine on cognitive functioning in healthy participants: a randomized, double-blind, placebo-controlled study

Randall L. Morrison, Maggie Fedgchin, Jaskaran Singh et al. · Psychopharmacology · 2018 · 70 citations · Full text